A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee
Public ClinicalTrials.gov record NCT00483977. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicentre Study To Assess The Efficacy And Tolerability Of PF-00592379 In Patients With Moderate To Severe Pain Due To Osteoarthritis
Study identification
- NCT ID
- NCT00483977
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 113 participants
Conditions and interventions
Conditions
Interventions
- Oxycodone Drug
- Placebo Drug
- PF-000592379 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2007
- Primary completion
- Nov 30, 2007
- Completion
- Nov 30, 2007
- Last update posted
- Apr 28, 2011
2007
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85741 | — |
| Pfizer Investigational Site | Carmichael | California | 95608 | — |
| Pfizer Investigational Site | Fair Oaks | California | 95628 | — |
| Pfizer Investigational Site | Orangevale | California | 95662 | — |
| Pfizer Investigational Site | Roseville | California | 95661 | — |
| Pfizer Investigational Site | Sacramento | California | 95825 | — |
| Pfizer Investigational Site | Boca Raton | Florida | 33486 | — |
| Pfizer Investigational Site | DeLand | Florida | 32720 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Longwood | Florida | 32779 | — |
| Pfizer Investigational Site | Miami | Florida | 33186 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40213 | — |
| Pfizer Investigational Site | Madisonville | Kentucky | 42431 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63141 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89146 | — |
| Pfizer Investigational Site | New York | New York | 10022-1009 | — |
| Pfizer Investigational Site | Durham | North Carolina | 27704 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45227 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45242 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00483977, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00483977 live on ClinicalTrials.gov.